• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 型 E CRISPR-Cas 系统影响. 中 -IncF 质粒的获得。

The type I-E CRISPR-Cas system influences the acquisition of -IncF plasmid in .

机构信息

Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

出版信息

Emerg Microbes Infect. 2020 Dec;9(1):1011-1022. doi: 10.1080/22221751.2020.1763209.

DOI:10.1080/22221751.2020.1763209
PMID:32393110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7301723/
Abstract

carbapenemase (KPC)-producing (KPC-KP) have disseminated worldwide and emerged as major threats to public health. Of epidemiological significance, the international pandemic of KPC-KP is primarily associated with CG258 isolates and -IncF plasmids. CRISPR-Cas system is an adaptive immune system that can hinder gene expansion driven by horizontal gene transfer. Because of -IncF plasmids are favored by CG258 it was of interest to examine the co-distribution of CRISPR and -IncF plasmids in such isolates. We collected 459 clinical in China and collected 203 global whole-genome sequences in GenBank to determine the prevalence of CRISPR-Cas systems. We observed that CRISPR-Cas system was significantly scarce in the CG258 lineage and -positive isolates. Furthermore, the results of conjugation and plasmid stability assay fully demonstrated the CRIPSR-Cas system in could effectively hindered -IncF plasmids invasion and existence. Notably, most -IncF plasmids were also proved to be good targets of CRISPR owing to carry matched and functional protospacers and PAMs. Overall, our work suggests that type I-E CRISPR-Cas systems could impact the spread of in populations, and the scarcity of CRISPR-Cas system was one of potential factors leading to the propagation of -IncF plasmids in CG258 .

摘要

产碳青霉烯酶 (KPC)-的 (KPC-KP) 已在全球传播,并成为公共卫生的主要威胁。具有流行病学意义的是,KPC-KP 的国际大流行主要与 CG258 分离株和 -IncF 质粒有关。CRISPR-Cas 系统是一种适应性免疫系统,可以阻止水平基因转移驱动的基因扩展。由于 -IncF 质粒受到 CG258 的青睐,因此研究此类分离株中 CRISPR 和 -IncF 质粒的共同分布情况很有意思。我们收集了中国的 459 株临床分离株,并从 GenBank 中收集了 203 株全球全基因组序列,以确定 CRISPR-Cas 系统的流行情况。我们观察到 CRISPR-Cas 系统在 CG258 谱系和 -阳性分离株中明显稀缺。此外,接合和质粒稳定性测定的结果充分证明了 中的 CRISPR-Cas 系统可以有效阻止 -IncF 质粒的入侵和存在。值得注意的是,由于携带匹配和功能的原间隔区和 PAM,大多数 -IncF 质粒也被证明是 CRISPR 的良好靶标。总的来说,我们的工作表明,I-E 型 CRISPR-Cas 系统可能会影响 中 传播,而 CRISPR-Cas 系统的稀缺性是导致 CG258 中 -IncF 质粒传播的潜在因素之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/2729b6605f35/TEMI_A_1763209_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/67e7da62911b/TEMI_A_1763209_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/b2a077199fbd/TEMI_A_1763209_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/351636bbb2dc/TEMI_A_1763209_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/4bb273e35364/TEMI_A_1763209_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/2729b6605f35/TEMI_A_1763209_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/67e7da62911b/TEMI_A_1763209_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/b2a077199fbd/TEMI_A_1763209_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/351636bbb2dc/TEMI_A_1763209_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/4bb273e35364/TEMI_A_1763209_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fbe/7301723/2729b6605f35/TEMI_A_1763209_F0005_OC.jpg

相似文献

1
The type I-E CRISPR-Cas system influences the acquisition of -IncF plasmid in .I 型 E CRISPR-Cas 系统影响. 中 -IncF 质粒的获得。
Emerg Microbes Infect. 2020 Dec;9(1):1011-1022. doi: 10.1080/22221751.2020.1763209.
2
CRISPR-Cas3 and type I restriction-modification team up against bla-IncF plasmid transfer in Klebsiella pneumoniae.CRISPR-Cas3 和 I 型限制修饰系统联手对抗肺炎克雷伯菌中 bla-IncF 质粒的转移。
BMC Microbiol. 2024 Jul 3;24(1):240. doi: 10.1186/s12866-024-03381-7.
3
High-risk KPC-producing Klebsiella pneumoniae lack type I R-M systems.高产型 KPC 肺炎克雷伯菌缺乏 I 型 R-M 系统。
Int J Antimicrob Agents. 2020 Aug;56(2):106050. doi: 10.1016/j.ijantimicag.2020.106050. Epub 2020 Jun 13.
4
Pandemic spread of bla among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids.在中国,肺炎克雷伯菌 ST11 中 bla 的流行与 IncFII 样质粒介导的水平转移有关。
Int J Antimicrob Agents. 2019 Aug;54(2):117-124. doi: 10.1016/j.ijantimicag.2019.03.014. Epub 2019 Mar 15.
5
Anti-Restriction Protein, KlcA, Promotes Dissemination of Carbapenem Resistance.抗限制蛋白KlcA促进碳青霉烯类耐药性的传播。
Front Cell Infect Microbiol. 2017 May 2;7:150. doi: 10.3389/fcimb.2017.00150. eCollection 2017.
6
A Novel Anti-CRISPR AcrIE9.2 Is Associated with Dissemination of Plasmids in Klebsiella pneumoniae Sequence Type 15.一种新型抗 CRISPR 蛋白 AcrIE9.2 与肺炎克雷伯氏菌 15 型序列型质粒的传播有关。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0154722. doi: 10.1128/aac.01547-22. Epub 2023 Mar 28.
7
CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.纽约市碳青霉烯类耐药肠杆菌科流行初期无β-内酰胺类耐药的肺炎克雷伯菌分离株。
J Antimicrob Chemother. 2019 Jan 1;74(1):17-21. doi: 10.1093/jac/dky394.
8
Molecular Analysis of -Harboring Plasmids: Tn Interplasmid Transposition and Tn-Carrying ColRNAI Plasmid Mobilization from Klebsiella pneumoniae to Citrobacter europaeus and Morganella morganii in a Single Patient.携带 - 基因的质粒的分子分析:肺炎克雷伯菌到肠杆菌属和摩氏摩根菌中单例患者体内的Tn 质粒转座和 Tn 携带 ColRNAI 质粒的转移。
mSphere. 2021 Dec 22;6(6):e0085021. doi: 10.1128/mSphere.00850-21. Epub 2021 Nov 3.
9
Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both and Integrated in the Chromosome.染色体上同时整合了[具体内容缺失]和[具体内容缺失]的多重耐药肺炎克雷伯菌的出现与进化
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00076-17. Print 2017 Jul.
10
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing.单一机构中产肺炎克雷伯菌碳青霉烯酶(KPC)的肺炎克雷伯菌:全基因组测序对地方流行性的见解
Antimicrob Agents Chemother. 2015 Mar;59(3):1656-63. doi: 10.1128/AAC.04292-14. Epub 2015 Jan 5.

引用本文的文献

1
Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review.产肺炎克雷伯菌碳青霉烯酶(KPC)革兰阴性临床分离株的全球流行病学及抗菌药物耐药性:综述
Microorganisms. 2025 Jul 19;13(7):1697. doi: 10.3390/microorganisms13071697.
2
Mechanistic study of the immune defense function of the CRISPR1-Cas system in .CRISPR1-Cas系统在……中的免疫防御功能的机制研究
Virulence. 2025 Dec;16(1):2530665. doi: 10.1080/21505594.2025.2530665. Epub 2025 Jul 15.
3
Genomic evolution and dissemination of non-conjugative virulence plasmid of ST65 carbapenem-resistant and hypervirulent strains in a Chinese hospital.

本文引用的文献

1
Absence of the type I-E CRISPR-Cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex.产Ⅰ-E 型 CRISPR-Cas 系统的缺失与肺炎克雷伯菌 258 克隆复合体中 IncF 流行耐药质粒的传播有关。
J Antimicrob Chemother. 2020 Apr 1;75(4):890-895. doi: 10.1093/jac/dkz538.
2
Distribution of CRISPR-Cas Systems in Clinical Carbapenem-Resistant Strains in a Chinese Tertiary Hospital and Its Potential Relationship with Virulence.中国一家三甲医院临床耐碳青霉烯类肠杆菌科细菌中 CRISPR-Cas 系统的分布及其与毒力的潜在关系。
Microb Drug Resist. 2020 Jun;26(6):630-636. doi: 10.1089/mdr.2019.0276. Epub 2019 Dec 13.
3
中国某医院中 ST65 碳青霉烯耐药且高毒力菌株非接合型毒力质粒的基因组进化与传播
Front Cell Infect Microbiol. 2025 Jun 12;15:1548300. doi: 10.3389/fcimb.2025.1548300. eCollection 2025.
4
ESBL-Producing and Exhibit Divergent Paths During In-Human Evolution Towards Carbapenem Resistance.产超广谱β-内酰胺酶菌株在人体内向碳青霉烯类耐药进化过程中呈现出不同路径。
Microorganisms. 2025 Jun 14;13(6):1387. doi: 10.3390/microorganisms13061387.
5
Mobile genetic elements in .中的可移动遗传元件 。 (原文表述不完整,翻译可能不太准确,你可补充完整原文以便更精准翻译)
J Bacteriol. 2025 May 22;207(5):e0001225. doi: 10.1128/jb.00012-25. Epub 2025 Apr 29.
6
Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFII KPC-2 plasmid.由IncFII KPC-2质粒驱动的耐碳青霉烯类高毒力肺炎克雷伯菌在全球出现。
EBioMedicine. 2025 Mar;113:105627. doi: 10.1016/j.ebiom.2025.105627. Epub 2025 Mar 1.
7
Intricate interplay of CRISPR-Cas systems, anti-CRISPR proteins, and antimicrobial resistance genes in a globally successful multi-drug resistant Klebsiella pneumoniae clone.在一个全球广泛传播的多重耐药肺炎克雷伯菌克隆中,CRISPR-Cas系统、抗CRISPR蛋白和抗菌耐药基因之间复杂的相互作用
Genome Med. 2025 Jan 30;17(1):9. doi: 10.1186/s13073-025-01428-6.
8
Comprehensive Analysis of CRISPR-Cas Systems and Their Influence on Antibiotic Resistance in Strains.CRISPR-Cas系统及其对菌株抗生素耐药性影响的综合分析
Bioinform Biol Insights. 2024 Dec 18;18:11779322241307984. doi: 10.1177/11779322241307984. eCollection 2024.
9
Detection of CRISPR‒Cas and type I R-M systems in of human and animal origins and their relationship to antibiotic resistance and virulence.检测人和动物源中的CRISPR-Cas和I型限制-修饰系统及其与抗生素耐药性和毒力的关系。
Microbiol Spectr. 2025 Feb 4;13(2):e0000924. doi: 10.1128/spectrum.00009-24. Epub 2024 Dec 19.
10
CRISPR-Cas3 and type I restriction-modification team up against bla-IncF plasmid transfer in Klebsiella pneumoniae.CRISPR-Cas3 和 I 型限制修饰系统联手对抗肺炎克雷伯菌中 bla-IncF 质粒的转移。
BMC Microbiol. 2024 Jul 3;24(1):240. doi: 10.1186/s12866-024-03381-7.
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread.
欧洲耐碳青霉烯类肺炎克雷伯菌的流行是由医院内传播驱动的。
Nat Microbiol. 2019 Nov;4(11):1919-1929. doi: 10.1038/s41564-019-0492-8. Epub 2019 Jul 29.
4
Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae.耐多药和毒力克隆肺炎克雷伯菌中水平基因转移的独特进化动态。
PLoS Genet. 2019 Apr 15;15(4):e1008114. doi: 10.1371/journal.pgen.1008114. eCollection 2019 Apr.
5
Pandemic spread of bla among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids.在中国,肺炎克雷伯菌 ST11 中 bla 的流行与 IncFII 样质粒介导的水平转移有关。
Int J Antimicrob Agents. 2019 Aug;54(2):117-124. doi: 10.1016/j.ijantimicag.2019.03.014. Epub 2019 Mar 15.
6
Systematic analysis of Type I-E Escherichia coli CRISPR-Cas PAM sequences ability to promote interference and primed adaptation.I 型-E 大肠埃希菌 CRISPR-Cas PAM 序列促进干扰和引物适应能力的系统分析。
Mol Microbiol. 2019 Jun;111(6):1558-1570. doi: 10.1111/mmi.14237. Epub 2019 Apr 6.
7
An Attenuated CRISPR-Cas System in Enterococcus faecalis Permits DNA Acquisition.粪肠球菌中一种减弱的 CRISPR-Cas 系统允许 DNA 的获取。
mBio. 2018 May 1;9(3):e00414-18. doi: 10.1128/mBio.00414-18.
8
High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences.I-E型级联CRISPR引导效率的高通量表征揭示了意外的PAM多样性和靶序列偏好。
Genetics. 2017 Aug;206(4):1727-1738. doi: 10.1534/genetics.117.202580. Epub 2017 Jun 20.
9
Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both and Integrated in the Chromosome.染色体上同时整合了[具体内容缺失]和[具体内容缺失]的多重耐药肺炎克雷伯菌的出现与进化
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00076-17. Print 2017 Jul.
10
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.耐碳青霉烯类肠杆菌科细菌的流行病学:一种全球威胁的影响与演变
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36. doi: 10.1093/infdis/jiw282.